Mechanisms Underlying Induction of Tolerance to Foods

Immunology and Allergy Clinics of North America

Volumn 36, Issue 1, 2016, Pages 87-102

  Berin, M Cecilia ^a   Shreffler, Wayne G ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Foxp3; IgE; IgG4; Immunotherapy; Microbiota; Tolerance; Treg

Indexed keywords

CELL MARKER; CYTOKINE; FOOD ALLERGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; MUCIN; IMMUNOGLOBULIN G;

ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; BASOPHIL; CELL SPECIFICITY; CELLULAR IMMUNITY; COMMENSAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DIETARY INTAKE; EVIDENCE BASED MEDICINE; FOOD ALLERGY; GASTROINTESTINAL DENDRITIC CELL; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LYMPHOCYTE FUNCTION; LYMPHOID CELL; NONHUMAN; PEANUT ALLERGY; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; TREATMENT RESPONSE; ANIMAL; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84947983135     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2015.08.002     Document Type: Review

References (74)

1. Wells H.G., Osborne T.B. The biological reactions of the vegetable proteins. I. Anaphylaxis. J Infect Dis 1911, 8:66-124.
2. Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
3. Fukaura H., Kent S.C., Pietrusewicz M.J., et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996, 98:70-77.
4. Weiner H.L., Cunha A.P., da Quintana F., et al. Oral tolerance. Immunol Rev 2011, 241:241-259.
5. Hadis U., Wahl B., Schulz O., et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011, 34:237-246.
6. Mucida D., Kutchukhidze N., Erazo A., et al. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005, 115:1923-1933.
7. Asseman C., Mauze S., Leach M.W., et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999, 190:995-1004.
8. Gonnella P.A., Waldner H.P., Kodali D., et al. Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis. J Autoimmun 2004, 23:193-200.
9. Chambers S.J., Wickham M.S.J., Regoli M., et al. Rapid in vivo transport of proteins from digested allergen across pre-sensitized gut. Biochem Biophys Res Commun 2004, 325:1258-1263.
10. Roth-Walter F., Berin M.C., Arnaboldi P., et al. Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy 2008, 63:882-890.
11. McDole J.R., Wheeler L.W., McDonald K.G., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 2012, 483:345-349.
12. Niess J.H., Brand S., Gu X., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258.
13. Rescigno M., Urbano M., Valzasina B., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367.
14. Kraus T.A., Brimnes J., Muong C., et al. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest 2005, 115:2234-2243.
15. Spahn T.W., Fontana A., Faria A.M., et al. Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol 2001, 31:1278-1287.
16. Spahn T.W., Weiner H.L., Rennert P.D., et al. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 2002, 32:1109-1113.
17. Worbs T., Bode U., Yan S., et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006, 203:519-527.
18. Cassani B., Villablanca E.J., Quintana F.J., et al. Gut-tropic T cells that express integrin α4β7 and cCR9 are required for induction of oral immune tolerance in mice. Gastroenterology 2011, 141:2109-2118.
19. Viney J.L., Mowat A.M., O'Malley J.M., et al. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998, 160:5815-5825.
20. Bogunovic M., Ginhoux F., Helft J., et al. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
21. Schulz O., Jaensson E., Persson E.K., et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009, 206:3101-3114.
22. Varol C., Vallon-Eberhard A., Elinav E., et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
23. Miller J.C., Brown B.D., Shay T., et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 2012, 13:888-899. Immunological Genome Consortium.
24. Coombes J.L., Siddiqui K.R.R., Arancibia-Cárcamo C.V., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007, 204:1757-1764.
25. Jaensson E., Uronen-Hansson H., Pabst O., et al. Small intestinal cD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 2008, 205:2139-2149.
26. Johansson-Lindbom B., Svensson M., Pabst O., et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med 2005, 202:1063-1073.
27. Matteoli G., Mazzini E., Iliev I.D., et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010, 59:595-604.
28. + dendritic cells. Immunity 2014, 40:248-261.
29. Kühn R., Löhler J., Rennick D., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
30. Shan M., Gentile M., Yeiser J.R., et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 2013, 342:447-453.
31. Mortha A., Chudnovskiy A., Hashimoto D., et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 2014, 343:1249288.
32. Atarashi K., Tanoue T., Oshima K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-236.
33. Atarashi K., Tanoue T., Shima T., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
34. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
35. Furusawa Y., Obata Y., Fukuda S., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
36. Faith J.J., Ahern P.P., Ridaura V.K., et al. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 2014, 6:220ra11.
37. Stefka A.T., Feehley T., Tripathi P., et al. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A 2014, 111:13145-13150.
38. Noval Rivas M., Burton O.T., Wise P., et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J Allergy Clin Immunol 2013, 131:201-212.
39. Noval Rivas M., Burton O.T., Wise P., et al. Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity 2015, 42:512-523.
40. Ohnmacht C., Park J.-H., Cording S., et al. The microbiota regulates type 2 immunity through RORγt+ T cells. Science 2015, 10.1126/science.aac4263.
41. Leonard S.A., Martos G., Wang W., et al. Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa. J Allergy Clin Immunol 2012, 129:1579-1587.e1.
42. Burton O.T., Noval Rivas M., Zhou J.S., et al. Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells. Immunity 2014, 41:141-151.
43. McLachlan J.B., Shelburne C.P., Hart J.P., et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med 2008, 14:536-541.
44. Hofmaier S., Hatzler L., Rohrbach A., et al. 'Default' versus 'pre-atopic' IgG responses to foodborne and airborne pathogenesis-related group 10 protein molecules in birch-sensitized and nonatopic children. J Allergy Clin Immunol 2015, 135:1367-1374.e1-8.
45. Hochwallner H., Schulmeister U., Swoboda I., et al. Patients suffering from non-IgE-mediated cow's milk protein intolerance cannot be diagnosed based on IgG subclass or IgA responses to milk allergens. Allergy 2011, 66:1201-1207.
46. Rowntree S., Cogswell J.J., Platts-Mills T.A., et al. Development of IgE and IgG antibodies to food and inhalant allergens in children at risk of allergic disease. Arch Dis Child 1985, 60:727-735.
47. Christmann B.S., Abrahamsson T.R., Bernstein C.N., et al. Human seroreactivity to gut microbiota antigens. J Allergy Clin Immunol 2015, 10.1016/j.jaci.2015.03.036.
48. Simón-Soro Á., D'Auria G., Collado M.C., et al. Revealing microbial recognition by specific antibodies. BMC Microbiol 2015, 15:132.
49. Shek L.P.C., Bardina L., Castro R., et al. Humoral and cellular responses to cow milk proteins in patients with milk-induced IgE-mediated and non-IgE-mediated disorders. Allergy 2005, 60:912-919.
50. Toit G., du Roberts G., Sayre P.H., et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med 2015, 372:803-813.
51. Berin M.C. Mucosal antibodies in the regulation of tolerance and allergy to foods. Semin Immunopathol 2012, 34:633-642.
52. Sicherer S.H., Wood R.A., Vickery B.P., et al. The natural history of egg allergy in an observational cohort. J Allergy Clin Immunol 2014, 133:492-499.
53. Martino D.J., Bosco A., Mckenna K.L., et al. T-cell activation genes differentially expressed at birth in CD4+ T-cells from children who develop IgE food allergy. Allergy 2012, 67:191-200.
54. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nat Immunol 2011, 12:5-9.
55. Miyara M., Yoshioka Y., Kitoh A., et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
56. Gavin M.A., Torgerson T.R., Houston E., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006, 103:6659-6664.
57. Hansmann L., Schmidl C., Kett J., et al. Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J Immunol 2012, 188:1275-1282.
58. Delong J.H., Hetherington Simpson K., Wambre E., et al. Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol 2011, 127(5):1211-1218.e3.
59. Brough H.A., Cousins D.J., Munteanu A., et al. IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. J Allergy Clin Immunol 2014, 134:1329-1338.e10.
60. Schmitt E., Germann T., Goedert S., et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 1994, 153:3989-3996.
61. Vickery B.P., Lin J., Kulis M., et al. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol 2013, 131:128-134.e1-3.
62. Burton O.T., Logsdon S.L., Zhou J.S., et al. Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol 2014, 134(6):1310-1317.e6.
63. Patil S.U., Ogunniyi A.O., Calatroni A., et al. Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects. J Allergy Clin Immunol 2015, 136(1):125-134.e12.
64. Hoh R.A., Joshi S.A., Liu Y., et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol 2015, 10.1016/j.jaci.2015.05.029.
65. Burks A.W., Jones S.M., Wood R.A., et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012, 367:233-243.
66. Thyagarajan A., Jones S.M., Calatroni A., et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy 2012, 42:1197-1205.
67. Gorelik M., Narisety S.D., Guerrerio A.L., et al. Suppression of the immunologic response to peanut during immunotherapy is often transient. J Allergy Clin Immunol 2015, 135:1283-1292.
68. Kulis M.D., Burk C., Yue X., et al. Basophil hyporesponsiveness following six months of Peanut Oral Immunotherapy (OIT) is associated with suppression of syk phosphorylation. J Allergy Clin Immunol 2015, 134:AB24.
69. Syed A., Garcia M.A., Lyu S.-C., et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014, 133:500-510.
70. Akdis C.A., Akdis M. Advances in allergen immunotherapy: aiming for complete tolerance to allergens. Sci Transl Med 2015, 7:280ps6.
71. Palomares O., Rückert B., Jartti T., et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol 2012, 129:510-520. 520.e1-9.
72. Scadding G.W., Shamji M.H., Jacobson M.R., et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 2010, 40:1-9.
73. Wambre E., Delong J.H., James E.A., et al. Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2014, 133:872-879.e7.
74. Jones S.M., Pons L., Roberts J.L., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124:292-297.